Bickerstaff's brainstem encephalitis: a rare case of neurologic complication in Ulcerative Colitis

被引:0
作者
Joo, Haram [1 ]
Lee, Chung Seok [1 ]
Joe, Sangwon [1 ]
Han, Jinu [2 ]
Kim, Han-Kyeol [1 ]
Cho, Hanna [1 ]
机构
[1] Yonsei Univ, Gangnam Severance Hosp, Coll Med, Dept Neurol, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea
关键词
Autoimmune encephalitis; Encephalitis; Bickerstaff's brainstem encephalitis; Ulcerative Colitis; Mesalazine; Inflammatory bowel disorder; INFLAMMATORY-BOWEL-DISEASE;
D O I
10.1186/s12883-023-03430-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Bickerstaff's brainstem encephalitis is a rare autoimmune disorder that presents with ataxia, ophthalmoplegia, disturbance of consciousness and quadriplegia. A 45-year-old man with a history of ulcerative colitis (UC) taking mesalazine (5-aminosalicylic acid) visited the emergency room presenting with ataxia, ophthalmoplegia and a progressively worsening cognitive impairment. Cerebrospinal fluid analysis showed mild elevation in protein and white blood cell count and increased intracranial pressure. Anti-GQ1b autoantibodies were found positive in the patient's serum and contrast-enhanced brain magnetic resonance imaging showed diffuse leptomeningeal enhancement and pontine lesions. Based on these findings and the patient's clinical course and history, he was diagnosed with Bickerstaff's brainstem encephalitis. Mesalazine was discontinued and high-dose steroid pulse therapy was started, followed by intravenous immunoglobulin, which resulted in gradual improvement of the neurologic symptoms. When an ulcerative colitis patient presents with progressive cognitive impairment, quadriplegia and disturbance of consciousness and gait, Bickerstaff brainstem encephalitis should be considered in the differential diagnosis and prompt immunotherapy may lead to favorable prognosis.
引用
收藏
页数:5
相关论文
共 15 条
[1]   Neurological events with tumour necrosis factor alpha inhibitors reported to the Food and Drug Administration Adverse Event Reporting System [J].
Deepak, P. ;
Stobaugh, D. J. ;
Sherid, M. ;
Sifuentes, H. ;
Ehrenpreis, E. D. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (04) :388-396
[2]   Severe neurological complications of ulcerative colitis [J].
Druschky, A ;
Heckmann, JG ;
Druschky, K ;
Huk, WJ ;
Erbguth, F ;
Neundorfer, B .
JOURNAL OF CLINICAL NEUROSCIENCE, 2002, 9 (01) :84-86
[3]   Autoimmune Encephalitis During Treatment With Adalimumab: A Case Report in Crohn's Disease [J].
Fernandez Alvarez, Paula ;
Maldonado Perez, Belen ;
Castro Laria, Luisa ;
Arguelles-Arias, Federico .
INFLAMMATORY BOWEL DISEASES, 2021, 27 (04) :E40-E41
[4]   Peripheral neuropathy incidence in inflammatory bowel disease A population-based study [J].
Figueroa, Juan J. ;
Loftus, Edward V., Jr. ;
Harmsen, William S. ;
Dyck, P. James B. ;
Klein, Christopher J. .
NEUROLOGY, 2013, 80 (18) :1693-1697
[5]   NEUROLOGIC ASPECTS OF INFLAMMATORY BOWEL-DISEASE [J].
LOSSOS, A ;
RIVER, Y ;
ELIAKIM, A ;
STEINER, I .
NEUROLOGY, 1995, 45 (03) :416-421
[6]   Inflammatory bowel disease: An increased risk factor for neurologic complications [J].
Moris, German .
WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (05) :1228-1237
[7]   Reversible Encephalopathy Due to Sulfasalazine [J].
Mut, Senem E. ;
Kutlu, Gulnihal ;
Ucler, Serap ;
Erdal, Abidin ;
Inan, Levent E. .
CLINICAL NEUROPHARMACOLOGY, 2008, 31 (06) :368-371
[8]   Bickerstaff's brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain-Barre syndrome [J].
Odaka, M ;
Yuki, N ;
Yamada, M ;
Koga, M ;
Takemi, T ;
Hirata, K ;
Kuwabara, S .
BRAIN, 2003, 126 :2279-2290
[9]   Anti-NMDAR encephalitis in Crohn's disease undergoing long-term infliximab treatment: A case report [J].
Oh, Shin Ju ;
Kwon, Young Nam ;
Lee, Chang Kyun ;
Lee, Jin San .
FRONTIERS IN IMMUNOLOGY, 2022, 13
[10]  
OLENGINSKI TP, 1991, J RHEUMATOL, V18, P304